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Membrane pore formationMany lantibiotics use the membrane bound cell wall precursor Lipid II as a speciﬁc target for killing Gram-
positive bacteria. Binding of Lipid II usually impedes cell wall biosynthesis, however, some elongated lantibiotics
such as nisin, use Lipid II also as a docking molecule for pore formation in bacterial membranes. Although the
unique nisin pore formation can be analyzed in Lipid II-doped vesicles, mechanistic details remain elusive. We
used optical sectioning microscopy to directly visualize the interaction of ﬂuorescently labeled nisin with mem-
branes of giant unilamellar vesicles containing Lipid II and its various bactoprenol precursors. We quantitatively
analyzed the binding and permeation capacity of nisinwhen applied at nanomolar concentrations. Speciﬁc inter-
actions with Lipid I, Lipid II and bactoprenol-diphosphate (C55-PP), but not bactoprenol-phosphate (C55-P),
resulted in the formation of large molecular aggregates. For Lipid II, we demonstrated the presence of both
nisin and Lipid II in these aggregates. Membrane permeation induced by nisin was observed in the presence of
Lipid I and Lipid II, but not in the presence of C55-PP. Notably, the size of the C55-PP–nisin aggregates was signif-
icantly smaller than that of the aggregates formedwith Lipid I and Lipid II. We conclude that themembrane per-
meation capacity of nisin is determined by the size of the bactoprenol-containing aggregates in the membrane.
Notably, transmitted light images indicated that the formation of large aggregates led to a pinch-off of small ves-
icles, a mechanism, which probably limits the growth of aggregates and induces membrane leakage.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The antimicrobial peptide nisin is produced by many strains of
Lactococcus lactis and is active against a broad range of Gram-positive
bacteria [1,2]. Nisin belongs to the group of lantibiotics, which areimide hydrazide; Atto488-NHS,
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ights reserved.characterized by intramolecular rings formed by the thioether amino
acids lanthionine and 3-methyllanthionine [3,4]. The peptide is a mem-
ber of the subgroup of type-A lantibiotics consisting of elongated,
screw-shaped peptides with a positive net charge.
Positively charged, antimicrobial peptides like nisin have the capac-
ity to adopt an amphipathic structure upon interaction with mem-
branes [5], and it has been suggested that nisin kills bacteria by
disturbing the integrity of the cell membrane [6]. Thus, it was shown
in model membrane studies that nisin destroys the membrane of
small unilamellar vesicles (SUVs) at micromolecular concentrations
[7]. However, when applied against Gram-positive bacteria, nisin
shows minimal inhibitory concentrations (MICs) in the nanomolar
range [8]. This observation argues against a simple membrane perfora-
tion mechanism as primary biological effect. In further studies the cell
wall precursor Lipid II was identiﬁed as a docking molecule. Evidence
that this interaction is crucial for killing bacteria was provided when it
was shown that the speciﬁc interaction of nisin and Lipid II leads to
pore formation [4]. In vitro studies revealed that nanomolar concentra-
tions of nisin were sufﬁcient to cause membrane perforation in Lipid II-
doped vesicles [7].
For bacteria, Lipid II is an indispensable constituent of the cell
membrane because it delivers the monomeric peptidoglycan units for
the cell wall biosynthesis. Thismakes it a prominent target for a number
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carbon chain, undecaprenyl-phosphate (bactoprenol-phosphate), cova-
lently coupled to the monomeric peptidoglycan unit through a
pyrophosphate linker. This unit is the basic building block of the cell
wall and consists of the two amino sugars N-acetylglucosamine (GlcNAc)
and N-acetylmuramic acid (MurNAc), with a pentapeptide bound to the
latter. Lipid II is assembled on the cytosolic face of the membrane by suc-
cessive enzymatic reactions (Fig. 1). The thereby generated intermediate
is named Lipid I, which is composed of undecaprenyl-diphosphate cova-
lently bound to MurNAc. Lipid II then translocates from the cytoplasmic
to the external side of the membrane. The mechanism of translocation
is not fully understood, but it is known that the integral membrane pro-
tein FtsW, an essential cell division protein, induces the trans-bilayer
movement of Lipid II in model membranes [10]. On the external face of
the membrane the insertion of peptidoglycan-units into the cell wall
is catalyzed. The remaining lipid anchor carrying the pyrophosphate,
C55-PP, is dephosphorylated to the monophosphate, C55-P, and shuttled
back to the cytosolic side of themembrane to start a new synthesis cycle.
The incubation of Gram-positive bacteria with nisin induces mem-
brane perforation, which leads to cell lysis [11]. In vitro studies showed
that stable membrane gaps with inner diameters of 2–2.5 nm can occur
[12]. At saturation the ratio of nisin molecules per Lipid II was proposed
to be 2:1 [13]. The speciﬁc interaction of nisin and Lipid II leads to theC55-PP
Lipid I Lipid II
peptidoglycan
cytoplasm
C55-P
TP
TG
Fig. 1. Cellwall biosynthesis cycle in S. aureus. In theﬁrstmembrane-linked step Lipid I is formed
carrier C55-P. Then, through linkage of UDP-GlcNAc to Lipid I, Lipid II is produced. Lipid II translo
the peptidoglycan unit is incorporated into the peptidoglycan network through the activity of p
actions. This leaves C55-PP, which is recycled through dephosphorylation, and the retrieved C5
Figure modiﬁed from [9].inhibition of cell wall biosynthesis as Lipid II is bound by nisin and sub-
sequently removed from the reaction cycle. Remarkably, when the in-
teraction of nisin with the bacterial membrane was directly observed
by using ﬂuorescently labeled nisin, the peptides were not homoge-
neously distributed on the bacterial membrane, but clustered in large
aggregates [14]. Clustering was also observed by direct imaging of ﬂuo-
rescent nisin on Lipid II containing giant unilamellar vesicles (GUVs)
[14]. The pyrophosphate unit of Lipid II was identiﬁed as a possible
structural binding motif for nisin, around which two lanthionine rings
of the peptide might form a cage structure [15]. Accordingly, binding
of nisin to C55-PP was observed, however no nisin-induced membrane
permeabilization in C55-PP-doped SUVs did occur [15]. Here, the ques-
tion remains why the speciﬁc binding of nisin to the pyrophosphate
does not lead to membrane destabilization.
To gain a deeper insight into the effect of nisin on Lipid II and its
bactoprenol precursors we used confocal laser scanning microscopy
(CLSM) to directly visualize the interaction of ﬂuorescently labeled
nisin with respective GUV membranes. We analyzed quantitatively
the binding behavior and permeation capacity of nisin when applied
in the MIC range. We discriminated between unspeciﬁc and speciﬁc in-
teractions, the ﬁrst driven by electrostatic forces and the latter
inﬂuenced by the binding sites that were offered to nisin. We found
that nisin formed large-scale aggregates when C55-PP, Lipid I or Lipidglucosamine
muramic acid
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at the inner face of themembrane by coupling theUDP-MurNAc-pentapeptide to the lipid
cates across themembranemediated by themembrane protein FtsW [10]. On the outside,
enicillin-binding proteins (PBPs) by transglycosylation (TG) and transpeptidation (TP) re-
5-P is available for the next biosynthesis cycle.
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membrane permeation when Lipid I or Lipid II were present in the
membrane, but not in the presence of C55-PP. Notably, the perforation
efﬁciency correlated with the size of the formed aggregates: Lipid I–
and Lipid II–nisin aggregates were comparable in size and about twice
as large as C55-PP–nisin aggregates. We concluded that the size of the
formed molecular aggregates determined the permeation capacity of
nisin. Suspiciously, we observed that at locations of large aggregates in
the membrane small vesicles pinched off the GUVs, what might be the
physical reason for the membrane permeability in such situations.
2. Material and methods
2.1. Chemicals and materials
All chemicals were of analytical grade or better. The phospholipids
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-
sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt, DOPG) were
purchased from Avanti Polar Lipids (Alabaster, AL, USA) and used with-
out further puriﬁcation. The lipids were dissolved in chloroform to a
ﬁnal concentration of 1.3 mM. Undecaprenyl-phosphate (C55-P) and
undecaprenyl-diphosphate (C55-PP) were purchased from Larodan
Fine Chemicals AB (Malmo, Sweden). The hydrophilic dye Lucifer
Yellow (LY) was purchased from Invitrogen (Karlsruhe, Germany).
Atto488-NHS ester (Sigma Aldrich, Schnelldorf, Germany) and Alexa
Fluor 647-hydrazide (Invitrogen, Karlsruhe, Germany) were used for
peptide labeling. Nisin Z was puriﬁed from culture supernatants of
L. lactis NIZO22186 [16] by chloroform extraction and HPLC [17]. Nisin
Z and nisin A are the two natural mutants of nisin. Nisin Z harbors the
amino acid asparagine at position 27 instead of histidine like nisin A.
We used nisin Z and simply refer to it as nisin. Puriﬁed nisin was lyoph-
ilized and stored at −20 °C. Nisin stock solutions were prepared in
0.005% acetic acid at a concentration of 1 mg/ml.
2.2. Synthesis and puriﬁcation of Lipid I and Lipid II
The lipid-bound cell wall precursor Lipid II was synthesized in vitro
and puriﬁed as described previously [18]. In vitro synthesis of Lipid I
was achieved by the omission of UDP-GlcNAc from the synthesis
assay, and Lipid II-Atto488 by using UDP-MurNAc-pentapeptide-
Atto488 instead of the non-labeled substrate. All reaction products
were extracted by butanol/6M pyridine acetate pH 4.2 and analyzed
by thin layer chromatography.
2.3. Labeling of the UDP-MurNAc-pentapeptide
The ﬂuorescent label was attached to the lysine residue of the penta-
peptide side chain in the UDP-MurNAc-pentapeptide, which had
been isolated and puriﬁed from Staphylococcus simulans 22 as described
[19]. For the labeling reaction UDP-MurNAc-pentapeptide was
dissolved in 0.1 M sodiumbicarbonate/acetonitrile (1:1, v/v). A solution
of Atto488-NHS ester was freshly prepared by the addition of dry DMSO
(1 mg/250 μl) and added stepwise to the UDP-MurNAc-pentapeptide
solution (molar ratio of UDP-MurNAc-pentapeptide:Atto488-NHS
ester of 2:1). The reaction mixture was incubated at room temperature
for 60 min and overnight at 4 °C under constant stirring, applied to a
C18 HPLC column, and puriﬁed using the following gradient: in
10 min from 0% to 20% B; 10 min isocratic at 20% B; in 10 min from
20% to 100% B (buffer A: 50 mM ammonium bicarbonate; buffer B:
100% methanol). UDP-MurNAc-pentapeptide-Atto488 containing frac-
tions were lyophilized and stored at−20 °C.
2.4. Production and puriﬁcation of ﬂuorescently labeled nisin
The carboxyl group of nisin was coupled to Alexa Fluor 647 (AF647)
using Alexa Fluor 647-hydrazide in conjunction with the water-solublecarbodiimide EDC. Nisin (5 mg/ml) was dissolved in 0.1 M MES-buffer,
pH 4.7–5.5. AF647-hydrazide was dissolved in dry DMSO (1 mg/60 μl)
and added to 0.5 ml nisin solution. Immediately before use, a 500 mM
EDC solution in 0.1 MMES-buffer was prepared and 14 μl of the EDC so-
lution was added to the reaction mixture, which was incubated over
night at room temperature. Nisin–AF647 was puriﬁed on a C18 column
using a linear gradient from buffer A (water, 0.1% triﬂuoroacetic acid,
TFA) to 100% buffer B (acetonitrile, 0.1% TFA).
2.5. Efﬂux experiments
Large unilamellar vesicles (LUVs) for carboxyﬂuorescein efﬂux ex-
periments were prepared by the extrusion technique as described pre-
viously [7]. 2 μmol DOPC and 0.75 μmol Lipid II (0.05 mol%) were
mixed in chloroform and the solvent was removed under a nitrogen
stream. The dried lipid ﬁlm was resuspended in 300 μl of buffer
(50 mM MES-sodium hydroxide, 100 mM sodium sulfate, pH 5.5),
which contained a self-quenched concentration of carboxyﬂuorescein
(50 mM). Lipids and buffer were swayed in a water bath at 30 °C by
hand and thenmixed thoroughly on a shaker until no lipid ﬁlmwas rec-
ognizable at the bottom of the tube anymore. The resulting suspension
of liposomes (multilamellar lipid vesicles) was then quick-frozen in
liquid nitrogen and thawed again in a water bath at 30 °C. The freeze–
thaw cycle was repeated 8–10 times. The resulting multilamellar vesi-
cles were extruded 21 times through 100 nm polycarbonate mem-
branes (Whatman, Kent, UK) by means of a MiniExtruder (Avanti
Polar Lipids, Alabaster, AL, USA). Unencapsulated carboxyﬂuorescein
was then removed by gel ﬁltration (Sephadex G-50, medium, Sigma
Aldrich, Schnelldorf, Germany). Fluorescence was measured in a glass
cuvette (Hellma Analytics, Müllheim, Germany) using a ﬂuorescence
spectrophotometer (LS55, PerkinElmer, Waltham, MA, USA, λex =
490 nm; λem = 525 nm). One hundred per cent carboxyﬂuorescein
leakage was determined by adding triton-X100, 1% (v/v).
2.6. GUV preparation
GUVswere created by electro-formation [20,21]. Vesicles containing
only phospholipidswere formed frompureDOPC or from an 80/20mix-
ture of DOPC and DOPG. For permeation and binding assays the same
mixtures each supplemented with 0.2 mol% C55P, C55PP, Lipid I or
Lipid II, respectively, were used. Twenty microliters of the respective
lipidmixture in chloroformwere deposited on an indium tin oxide coat-
ed coverslip (SPI Supplies, West Chester, PA, USA), and then dried in a
desiccator under vacuum. The dried lipid ﬁlm was hydrated with
250 mM sucrose in bi-distilled water as described in [22].
2.7. Sample preparation for confocal microscopy
For measurements, 250 mM glucose in deionized water or buffer
(125 mM glucose, 30 mM MES, 35 mM sodium sulfate, pH = 5.8)
were mixed with nisin–AF647 and LY before GUV addition. Nisin–
AF647was diluted to a ﬁnal concentration of 1.5 μM for the observation
of non-speciﬁc and speciﬁc binding. For translocation analysis nisin–
AF647 was diluted to 0.2 μM and LY to a concentration of 20 μM. For
binding analysis the same nisin–AF647 concentration was used. 50 μl
of vesicle bulk solutionwere transferred into amicroscope sample cham-
ber (MatTek, Ashland, MA, USA) containing 200 μl of the respective glu-
cose or buffer solution. The density difference causedGUV sedimentation,
so that the liposomes could be examined by CLSM. Data acquisition was
started after 3 min incubation time, when the vesicles resided in a stable
position at the chamber bottom.
2.8. Confocal laser scanning microscopy (CLSM)
GUV formation, incorporation of Lipid II-Atto488 into GUVs and in-
teractions between GUVs and nisin–AF647 were examined by CLSM
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Fig. 2. Charge-driven and speciﬁc interaction of nisin–AF647 with phospholipid GUVs.
Confocal images of nisin–AF647 at 1.5 μM acting on GUVs: (A) DOPC membranes in glu-
cose solution, (B) DOPC/DOPG (80/20) membranes in glucose solution, and (C) DOPC/
DOPG (80/20) membranes in buffer. In (D) to (F) GUVs contained 0.2 mol% Lipid II:
(D) DOPCmembranes in glucose solution, (E) DOPC/DOPG (80/20)membranes in glucose
solution, and (F) DOPC/DOPG (80/20) membranes in buffer. GUVs were imaged at 5 min
after incubation starts. Scale bar, 20 μm.
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equipped with a water immersion C-Apochromat 40× objective lens
(NA 1.2, Corr) and a Plan-Neoﬂuar 20× air objective lens (NA 0.5) at
room temperature. LY and Lipid II-Atto488 were excited with the light
of an argon ion laser at 488 nm, and nisin–AF647 was excited using a
He–Ne laser at 633 nm. Laser beams were directed to the sample by
means of a UV/488/543/633 dichroic beam splitter. For ﬂuorescence de-
tection a secondary 545 dichroic beam splitter supplemented with a
BP505-550 ﬁlter and a LP650 ﬁlter were used. For comparative mea-
surements the same settings for illumination intensity and detector
gain were applied.
2.9. Image colocalization analysis
Analysis of the two-color images was done using ImageJ [23]
with the colocalization highlighter plugin (authored by Christophe
Laummonerie, Jerome Mutterer, Institute de Biologie Moleculaire des
Plantes, Strasbourg, France). The threshold was set to the mean of the
background plus three times the standard deviation. Pixels with the
same coordinates in the two ﬂuorescence images were regarded as
colocalized when intensity values were above the respective threshold
in both images. Images of the two detection channels were merged,
and colocalized pixels were highlighted in white.
2.10. Translocation analysis
The translocation of LY across GUV membranes was analyzed by
ImageJ [23]. Generally, GUVs with a radius R smaller than 20 μm were
excluded from analysis. To identify the GUVs for the analysis, an inten-
sity thresholdwas deﬁned that separated theGUVs (low intensity) from
the remaining solution (high intensity). This worked well since the in-
tensity difference between GUV interior and exterior was usually high
at the beginning of the measurement. The GUVs were then identiﬁed
using the particle analysis tool of ImageJ. For these GUVsmean intensity
values for their interior, Fin, were determined, and also the ﬂuorescence
intensity outside the GUVs, Fout. The ratio Fin/Fout was used as ameasure
for membrane permeation. This ratio was determined for all GUVs at
certain time points after nisin incubation starts. Finally, the ratios
were plotted in histograms presenting the data of at least 30 analyzed
GUVs for each experimental condition. Signiﬁcance of the datawas test-
edwith an independent, two-sample t-test. p-Valueswere calculated by
the use of Matlab (MathWorks, Ismaning, Germany) and signiﬁcance
indicated in the diagram by labeling the respective bars with asterisks
(three asterisks for p b 0.005, two asterisks for p b 0.01 and one asterisk
for p b 0.1).
2.11. Aggregate analysis
Analysis of nisin–AF647 aggregates on GUV membranes was
performed by the use of ImageJ and a dedicated Matlab routine
(MathWorks, Ismaning, Germany). First, images were linearized along
the equatorial membrane of the GUVs with the ImageJ polar transform-
er plugin (authored by Edwin Donnelly, Vanderbilt University School of
Medicine, Nashville, USA and Frederic Mothe, Centre INRA de Nancy,
Champenoux, France). Thereby, the circular intensity proﬁle of the
membrane was converted into a linear proﬁle. The distribution of the
intensity values along this linewas determined, and ﬁtted by a Gaussian
function. The obtained values for the mean, F , and the standard varia-
tion, σ, were used for normalization of the intensity values according
to Fn = (F−F) / σ. In the next step, molecular aggregates were identi-
ﬁed as peaks in the normalized intensity proﬁle by Fn N 3. The peak in-
tensity value was related to the number of ﬂuorescent molecules in
the detected aggregate, and could therefore be used as a measure
for the cluster size. From the number of peaks along the circular GUV
proﬁle the aggregate density permembrane lengthwas calculated. Nor-
malization, peak identiﬁcation and cluster analysis were automaticallyperformed by the Matlab routine. Generally, the equatorial membrane
sections of more than 20 GUVs were evaluated for each experimental
condition. Signiﬁcance of the data was tested as described in
Section 2.10.
3. Results
GUVs represent a well controllable membrane model system, and
are well suited to systematically monitor the action of membrane active
peptides on bilayers and therein incorporated receptors [22,24].We ex-
amined the interaction of ﬂuorescently labeled nisin with pure phos-
pholipid GUVs and also GUVs that contained the target molecule of
nisin, Lipid II, or one of its derivates by optical sectioning microscopy.
In the beginning, we veriﬁed that the activity of labeled and unlabeled
nisin did not differ signiﬁcantly by means of a carboxyﬂuorescein leak-
age assay (Fig. S1). Indeed, the activity of the labeled molecule was
slightly higher than that of the unlabeled species.
3.1. Interaction of nisin with pure phospholipid GUVs and GUVs containing
Lipid II
Firstly, we investigated the non-speciﬁc interactions of nisin with
membranes in order to discriminate them from speciﬁc effects due to
binding to targets such as Lipid II. We incubated GUVs prepared from
DOPC and DOPC/DOPG in glucose solutions containing 1.5 μM red-
ﬂuorescent nisin–AF647. Interaction of nisin–AF647 with the GUVs
was observed by CLSM in the equatorial plane directly after mixing
and within less than 5 min incubation. For GUVs made from neutral
DOPC all nisin–AF647 remained in the solution, which was indicated
by the bright ﬂuorescence outside the GUVs. No binding of nisin–
AF647 to the GUV surface was observed (Fig. 2A). In contrast to
this, for GUVs comprising DOPC and 20% negatively charged DOPG in-
stantaneous binding of nisin–AF647 to the membrane was seen as the
nisin-AF647
colocalized
A
B
Lipid II-Atto488
Lipid II-Atto488
before
after nisin addition
transmitted light
Fig. 3. Aggregation of Lipid II-Atto488 and nisin–AF647. Membrane distribution of Lipid II
in DOPC GUVs containing 0.2 mol% Lipid II-Atto488 before addition of nisin (A) and after
incubation in 250 mM glucose solution containing 200 nM nisin–AF647 (B). White pixels
in the merged image mark colocalized nisin–AF647 and Lipid II-Atto488. The transmitted
light image revealed the formation of small vesicles at the location of the nisin–Lipid II ag-
gregates (see arrows). GUVs were imaged after 5 min incubation with nisin. Scale bar,
10 μm.
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emanated from the surrounding solution (Fig. 2B). Furthermore, we ob-
served numerous small liposomes in the solution (Fig. 2B), probably due
to a decomposition of GUVs as a consequence of peptide accumulation
on the membrane. When the experiment was repeated in buffer solu-
tion, accumulation of nisin on the GUV surface and also vesicle decom-
position were largely reduced (Fig. 2C). Reduction of peptide binding
was indicated by a considerably weaker ﬂuorescence signal from
the membrane and stronger ﬂuorescence from the GUV environment
compared to the incubation in sugar solution. Obviously, in thepresence
of ions, membrane and peptide charges were shielded, which reduced
the effective attractive electrostatic forces between the negatively
charged membrane and the positively charged peptide with its net
charge of +3.
Next,we preparedGUVs containing Lipid II (0.2 mol%). In contrast to
neutral, pure DOPC GUVs, Lipid II-containing DOPC GUVs in glucose so-
lution rapidly bound nisin–AF647 (Fig. 2D). Accordingly, only ﬂuores-
cence was observed from peptides in solution. Notably, in contrast to
charge-induced interactions (Fig. 2B), membrane binding was not ho-
mogeneous, but bright ﬂuorescent patches of nisin–AF647 appeared
on the GUV membranes, which indicated the formation of large
molecular aggregates. In order to examine whether the aggregates
contained both nisin and Lipid II we used dual color ﬂuorescence.
When integrated in DOPC liposomes, green ﬂuorescent Lipid II-Atto488
was homogeneously distributed in the GUV bilayer before addition of
nisin, but following addition of nisin–AF647 it formed aggregates
(Fig. 3). Colocalization analysis clearly indicated that the aggregates
contained both nisin–AF647 and Lipid II-Atto488. We concluded that
the speciﬁc binding of nisin to Lipid II results in the rapid formation of
large-scale molecular nisin–Lipid II-aggregates in the GUV membrane.
Interestingly, the image of the transmitted light channel showed that
exactly at the location of the larger aggregates small vesicles formed
(indicated by arrows in Fig. 3B) that were released from the GUVs.
When anionic GUVs (80% DOPC, 20% DOPG) were supplemented
with Lipid II (0.2 mol%) and incubated in nisin–AF647–glucose solution,
a mixture of unspeciﬁc and speciﬁc binding occurred: due to electro-
static forces nisin attached homogeneously to the negative charges of
the membrane, but was also speciﬁcally binding to Lipid II. Again, this
was indicated by the formation of membrane aggregates (Fig. 2E). The
presence of ions slightly reduced the charge-driven binding to the
membrane, but did not affect the formation of aggregates (Fig. 2F).
3.2. Nisin caused membrane permeability
Since it was not feasible to evaluate the permeation of the GUVmem-
brane by the analysis of the nisin signal due to the strong membrane ac-
cumulation that usually occurred, we examined membrane permeation
induced by nisin by using a small hydrophilic tracer dye, LY. LY exhibits
a Stokes diameter of 1.2–1.5 nm,which is smaller than the previously re-
ported diameter of pores formed by nisin and Lipid II [12]. For these
translocation experiments, GUVs were incubated with nisin–AF647 at a
concentration of 200 nM. This concentration was low enough to be in
thenanomolar range of the nisinMIC, and still high enough for proper vi-
sualization of the interactions of nisin–AF647with GUVs by confocal mi-
croscopy. Thus, we were able to correlate nisin binding and membrane
permeation in terms of tracer translocation.
We followed the intensity distribution of the tracer ﬂuorescence in-
side andoutside of GUVs for various experimental conditions for 15 min
upon application of nisin–AF647. As a permeability measure we used
the ratio of the tracer ﬂuorescence intensity inside, Fin, and outside the
GUVs, Fout. For equilibration of the tracer, the ratio Fin/Fout equals 1.
The ratio was determined for a set of vesicles as a function of incubation
time. Fig. 4A shows the tracer ﬂuorescence, when nisin acted on Lipid II-
containing GUVs, for one representative experiment. We noticed that
the response of the GUVs to nisin was very heterogeneous. In the
lower panel of Fig. 4A we plotted the ratio of the tracer ﬂuorescencefor GUVs of repeated experiments in histogram form. Obviously, the
number of permeabilized GUVs (with Fin/Fout ≈ 1) increased with
time. In order to present the results of these permeation experiments
in a more compact form we determined the mean values of the ratios
in these histograms, and plotted them as a function of time (Fig. 4B).
In the presence of nisin an increase of permeability over time was
observed for allmembrane compositions (Fig. 4B). For pure phospholip-
id GUVs the effect of 200 nM nisin was relatively small. For both DOPC
and DOPC/DOPG GUVs only a small increase in membrane permeability
with timewas observed. A comparable permeation levelwas seen at the
start of the experiment, and a similar dependence on incubation time
was observed. At the used concentration in the MIC range nisin did
not affect membrane intactness neither in neutral nor in negatively
charged GUVs signiﬁcantly.
The situation was very different, when the GUV membrane
contained Lipid II or further molecules that are known to be nisin
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Fig. 4. Membrane permeation activity of nisin. In all experiments the fraction of
bactoprenol components was 0.2 mol% and of DOPG 20 mol%. GUVs were incubated in
250 mM glucose solution containing 200 nM nisin–AF647 and 30 μM LY. (A) Time series
of DOPC-GUVs containing Lipid II. The upper panel displays the intensity distribution of LY
at the time points 5 min, 10 min and 15 min after nisin addition. White arrows indicate
three vesicles which exhibit differing permeability kinetics. The lower panel shows the
distribution of the intensity ratio Fin/Fout at the respective time points. For the histograms
in (A) values of 48 liposomes were evaluated. (B) Mean ratios for different membrane
compositions were calculated at the respective time points. Permeability increased over
time. The independent, two-sample t-test, executed for ratios measured after 15 min,
yielded p-values b 0.001 for Lipid I- and Lipid II-containing vesicles compared to DOPC
vesicles (indicated by three asterisks at bars). Permeability was not signiﬁcant for other
mixtures.
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Lipid II cycle in order to specify exactly, what the most effective target of
nisin was. All results were summarized in Fig. 4B.
As expected from the previous results, nisin caused a strong mem-
brane permeability of Lipid II-containing GUVs. Also, the permeability
was reduced, when negatively charged Lipid II-containing GUVs made
from DOPC and DOPGwere studied. Then, the effect of nisin was clearly
less pronounced than on neutral GUVs. Lipid I-containing GUVs were
permeabilized by nisin almost as potently as Lipid II-containing GUVs.
Again, this was expected, since the pyrophosphate binding site of
Lipid I possesses the same chemical environment as in Lipid II, namelythe isoprene chain on one side and N-acetylmuramic acid with the pen-
tapeptide chain on the other side, which seems to attract nisin interac-
tion in almost the same way for Lipid I and Lipid II. On the other hand,
C55-P containing GUVs did not show a greater permeabilization than
that of neutral and anionic GUVs. This was not surprising, since the
phosphate headgroup of C55-P is not a binding site for nisin in contrast
to C55-PP-containing GUVs. For these, no increased membrane perme-
ability was observed at all, although nisin was known to bind the pyro-
phosphate of C55-PP [15]. Indeed, a failure to induce membrane
permeation upon nisin binding to C55-PP had also been observed before
for small vesicles [25]. Obviously, binding of nisin alone was not sufﬁ-
cient to lead to membrane permeation. Therefore, we decided to exam-
ine, whether the characteristic aggregation that had been observed
upon nisin binding to Lipid II, could be observed for C55-PP as a conse-
quence of the nisin interaction.
3.3. Nisin effect on different bactoprenol derivatives
Usingﬂuorescent nisin enabled us to analyze the aggregates in terms
of size, since this was related to the ﬂuorescence intensity of the aggre-
gates. Furthermore, by confocal imaging of respectively prepared GUVs
the number of aggregates per unit length along the membrane equator
could be determined, and was used as a measure for the general aggre-
gate surface density.
By confocal imaging a 2-dimensional, equatorial section of the GUVs
with an axial depth of about 1 μm can be mapped. For the quantitative
analysis of nisin binding and aggregation this ring-shaped proﬁle was
linearized. Fig. 5A shows different exemplary GUV sections, which dem-
onstrate the different types of nisin interaction that were observed. For
neutral DOPC vesicles no binding was observed (Fig. 5A, upper image,
see also Fig. 2A), whereas for DOPC/DOPG-GUVs strong and homoge-
neous binding occurred (Fig. 5A, central image, see also Fig. 2B). Lipid
II-containing GUVs showed a third situation. There, the section revealed
ﬂuctuating intensities along the membrane due to strong nisin–AF647
aggregation (Fig. 5A, lower image, see also Fig. 2D). For the three
examples, pixel intensity values were determined along the membrane
and plotted in a histogram (Fig. 5B). The various intensity distributions
of nisin–AF647 illustrate the differences in nisin–membrane interaction.
A Gaussian-like distribution was obtained when nisin was not inter-
acting with the GUVs (Fig. 5B, blue bars) and also, but at higher intensi-
ties, when nisin was homogeneously bound to the membrane through
charge-driven interactions (Fig. 5B, green bars), but not in the case of
aggregate formation (Fig. 5B, red bars). Here, a number of bars did not
ﬁt into the normal distribution, but occurred at higher intensities.
These intensities corresponded to the nisin–AF647 aggregates. As de-
scribed in the Material and methods the intensity distributions were
ﬁtted by a Gaussian function.With the thus determinedmean and stan-
dard deviation the intensity proﬁles were normalized (Fig. 5C). The in-
tensity proﬁles show that for the DOPC membrane (Fig. 5C, blue line)
and for the DOPC/DOPG-GUV membrane (Fig. 5C, green line) all values
lie around the baseline (Fig. 5C, black line) under a certain threshold
(Fig. 5C, dashed line). Only the proﬁle for the Lipid II-containing mem-
brane showed pronounced peaks above the threshold. These peaks, re-
ferring to nisin aggregates, could well be detected and quantiﬁed by a
Matlab software program (see Material and methods). To determine
the size of the aggregates, we calculated the mean peak intensity for
each sample from at least 15 GUVs. In addition, the analysis yielded
the aggregate number per unit membrane length respectively the ag-
gregate density (Fig. 5D).
We quantiﬁed the aggregates for all GUV types that were examined
above, and found that Lipid II-containing GUVs exhibited the highest
density of nisin aggregates, and also, with Lipid I-containing GUVs, the
largest ones (Fig. 5D). For Lipid II-, Lipid I- and C55-PP-containing GUVs
a similar aggregate density was found, which was signiﬁcantly higher
than that of C55-P-containing, DOPC/DOPG and DOPC GUVs. However,
the aggregate sizes for Lipid II and Lipid I were signiﬁcantly larger
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Fig. 5.Quantiﬁcation of nisin–AF647 clustering in GUVmembranes. (A) Linearized proﬁle of the nisin–AF647 ﬂuorescence signal along themembrane of GUVs of different composition as
indicated (incubation time, 5 min); (B) histogram representation of theﬂuorescence intensity values along the line proﬁles shown in (A); (C) plot of the normalized intensity values along
the GUVmembranes shown in (A). Nisin–AF647 clusters showed signiﬁcantly higher intensity values (red) than the baseline intensity (full black line, deﬁned as zero). The dashed black
line indicates the threshold intensity of 3*σ. (D)Mean peak intensities (blue) andmean aggregate densities (gray) for differentGUV-phospholipid and bactoprenol compositions. Standard
errors of the mean are given by error bars. At least 15 GUVs for each membrane composition were analyzed (DOPC: N = 24, DOPC/DOPG: N = 20, DOPC/C55-P: N = 19, DOPC/C55-PP:
N = 28, DOPC/Lipid I: N = 15, DOPC/Lipid II: N = 21). Signiﬁcancewas tested (independent, two-sample t-test) between the values determined for negatively charged and bactoprenol-
containing membranes and the values determined for DOPC membranes. When signiﬁcant, it was indicated by asterisks (*** for p b 0.005 and ** for p b 0.01).
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size difference was also observed between C55-P and C55-PP aggregates.
C55-PP aggregates were signiﬁcantly larger than those occurring in
DOPC membranes, whereas C55-P aggregates were not (Fig. 5D). As an-
ticipated, for GUVs made from pure DOPC, DOPC/DOPG, and DOPC con-
taining C55-P the aggregates induced by nisin were small in size and
number.
In summary, for all GUV mixtures that allowed only non-speciﬁc
nisin interactions, small clusters and a low density were observed. In
all mixtures that contained speciﬁc binding partners for nisin and for
which nisin-inducedmembrane permeation was observed, large molec-
ular aggregateswere seen. Interestingly, themean peak intensities of the
aggregates induced by nisin in Lipid I- and Lipid II-containing GUVswere
comparable. Obviously, approximately the same number of nisin mole-
cules was accumulated in these clusters. This suggested that a speciﬁc
process inhibited a further growth of the clusters. Examination of the im-
ages shown in Figs. 2D to F, 3 and 5A indicated that this process could be
a pinch-off of small vesicles containing nisin aggregates.
4. Discussion
Lipid II with its central role in building the bacterial cell wall belongs
to the important targets of many classes of current antibiotics [26].
Here, we focused on the effect of the lantibiotic nisin on Lipid II and
its bactoprenol precursors. To this end, we incorporated the variousbactoprenol derivatives in GUV membranes and studied membrane
perforation and bactoprenol aggregation induced by nisin in a quantita-
tivemanner. The goal of this studywas to improve our understanding of
the mode of action of the lantibiotic nisin.
Previously, it was shown in model membrane studies that nisin
destroys the membrane of small unilamellar vesicles (SUVs) at
micromolecular concentrations [7]. When applied at such concentra-
tions the peptide was by one order of magnitude more effective in
perforating negatively charged compared to neutral membranes dem-
onstrating that membrane charge is important for the direct interaction
of nisinwithmembranes. This was corroborated by AFM studies on pla-
nar model membranes, on which nisin at 1.5 μM generated micellar or
vesicular associates upon contact with anionic, but not with neutral
membranes [27]. In most of our experiments, however, nisin was ap-
plied at a concentration of 200 nM only. This concentrationwas chosen
such that nisin would bind the majority of Lipid II molecules, when
present in the membrane, because the respective dissociation constant
is 50 nM [27]. Also, this value was in the range of the MIC of nisin
against Gram-positive bacteria [8].
As expected we found that a negative membrane charge enhanced
peptide accumulation at the GUV membrane, but a signiﬁcant mem-
brane perforation did not occur for neutral or negatively charged
GUVs at 200 nM. This result conﬁrmed that charge-driven membrane
permeabilization of nisin is concentration dependent, and does not
play a major role in the range of the biologically relevant MIC.
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distinctly different effects. Nisin binding to Lipid II provoked a drastic
change of the Lipid II distribution in the membrane. Lipid II accumulated
in large complexes together with nisin as was assumed in a previous
study in vitro and in vivo [14]. Here, we explicitly demonstrated for the
ﬁrst time that the aggregates induced by nisin contain both large num-
bers of nisin and Lipid II molecules by colocalizing respectively ﬂuores-
cently labeled molecules. It can be anticipated that this is also the case
for the other examined bactoprenol derivatives. For Lipid II, aggregation
was accompanied by membrane permeation, which was shown by the
inﬂux of tracer molecules with a diameter of 1.5 nm into the GUVs.
The amount of permeation differed greatly between single GUVs.
Large differences between individual GUVs were generally observed in
our kinetic measurements. We assume that this was due to the fact
that the formation of membrane perforations by amphipathic peptides
is a stochastic process and highly dependent on local peptide concentra-
tions [28]. A negative charge in Lipid II-containing GUVs decreased the
permeation activity of nisin probably because two components, the an-
ionic lipid head group and Lipid II, competed for nisin [27].
Nisin bound to and formed aggregates alsowith Lipid I, andperforat-
ed the membrane similar as upon interaction with Lipid II. This was
expected since Reisinger and coworkers discovered already in 1980
that nisin forms complexes with Lipid I thus inhibiting Lipid II synthesis
[29]. However, Lipid I is not a primary target of nisin in vivo since it re-
sides on the cytoplasmic face of bacterial membranes. But due to the
demonstrated membrane permeation translocation of nisin across the
cell membrane is possible and Lipid I may probably also be targeted.
Hsu and coworkers unambiguously demonstrated the central role of
Lipid II's pyrophosphate group for the interaction with nisin [15], but
also stated that it is presumably a necessary, but not a sufﬁcient deter-
minant. In agreement with this no speciﬁc interaction with C55-P, but
with C55-PP was detected, even though the afﬁnity of nisin for Lipid II
was found to be twice as high [30]. Interestingly, in our direct visualiza-
tion of GUV membranes we observed that nisin formed aggregates
when C55-PP was present in the membrane, but the aggregates were
clearly smaller than those formed with Lipids I and II. Remarkably, the
nisin–C55-PP aggregates left the membrane intact, whereas the mem-
brane was perforated by nisin–Lipid I and nisin–Lipid II aggregates
very effectively. For Lipids I and II, whose interactionwith nisin resulted
inmembrane perforation, the samemean cluster sizewas observed.We
suspect that a quorum of assembledmolecules was required for an efﬁ-
cient membrane perforation.
Several recent molecular dynamics simulations of the action of bio-
active peptides revealed the importance of the distortion of membrane
topology bymembrane-active peptides for creatingmembrane pores or
large-scale membrane perforations [31,32]. In these simulations it was
found that the bioactive maculatin 1.1 or TAT peptides induced a nega-
tive membrane curvature, and magainin 2 even provoked vesicle bud-
ding [33]. We suspect that this is also the case for Lipid II-bound nisin,
aswe generally observed the formation of small vesicles at the locations
of Lipid II–nisin aggregates. This observation suggests a major role for
large-scale alterations of themembrane topology during the perforation
process. Of course, it remains to be shown that such vesicle budding
upon nisin addition also occurs in vivo, possibly at least partially.
In the seemingly simple nisin–Lipid II system we encountered a re-
markable biophysical effect. Binding of an effector molecule – nisin –
to its membrane-anchored target caused the dramatic and large-scale
aggregation of the latter— C55-PP, Lipid I or Lipid II. The physical driving
force for this aggregation process is still quite unclear. It is not probable
that it is due to direct molecular interactions, because these would
lead only to the formation of multimers of limited size — but not to
the formation of light-microscopically visible molecular aggregates
comprising hundreds or thousands of molecules. Molecular dynamics
simulations similar to those that were recently performed to study the
Lipid II–vancomycin interaction and its consequences for the lipid bilay-
er properties would probably contribute to a physical understanding ofthe membrane-associated aggregation process [34]. The driving force
acting in this simple molecular system is of greatest importance for un-
derstanding the action principle of lantibiotics. Possibly, it is also of im-
portance for further signaling processes involving membrane receptors
responding to their signals.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2013.07.014.
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